CRV Ambreed has taken delivery of a $450,000 machine that will increase capacity for herd-testing in New Zealand and from later this year will provide more detailed information on mastitis for farmers.
The machine arrived in New Zealand from Denmark late last year and has been installed and calibrated on CRV Ambreed’s behalf at MilkTest NZ in Hamilton.
CRV Ambreed Managing Director Angus Haslett says the new machine, a Milkoscan FT+, has immediately boosted herd-testing capacity to 800 samples an hour, providing farmers with analysis on individual cows’ production while also identifying high and low performers in a herd.
“The second part to this machine, the Fossomatic 7 DC, will be released onto the market in the first half of 2017, and will work in combination with the Milkoscan FT+ to provide advanced forms of somatic cell count analysis.”
Mr Haslett says this advanced analysis will help farmers manage mastitis in herds. The Somatic Cell Count analysis capacity will provide information about what stage the mastitis is at, helping farmers make strategic decisions around medical treatment that might be needed, including the amount of antibiotics used.
“This is the latest technology available from FOSS in Denmark which runs a huge Research and Development arm and is always innovating in the herd-testing market,” says Mr Haslett. “We’re pleased to be able to bring this level of innovation and investment to dairy farmers in New Zealand.”
Part one of the new machine is already in use in conjunction with CRV Ambreed’s existing machine at MilkTest NZ. The second part of the machine is due in New Zealand in the first half of 2017.
Regular herd-testing is used to monitor and estimate production for individual cows, and for cow health. CRV Ambreed recommends herd-testing schedules are planned in advance so current herd production information is ready in time for farm management decisions such as drying-off, culling, or preventive treatment of animal health issues.